237 related articles for article (PubMed ID: 21946431)
21. Dynamic range of GSK3α not GSK3β is essential for bidirectional synaptic plasticity at hippocampal CA3-CA1 synapses.
Shahab L; Plattner F; Irvine EE; Cummings DM; Edwards FA
Hippocampus; 2014 Dec; 24(12):1413-6. PubMed ID: 25208523
[TBL] [Abstract][Full Text] [Related]
22. The inhibition of glycogen synthase kinase 3beta by a metabotropic glutamate receptor 5 mediated pathway confers neuroprotection to Abeta peptides.
Liu F; Gong X; Zhang G; Marquis K; Reinhart P; Andree TH
J Neurochem; 2005 Dec; 95(5):1363-72. PubMed ID: 16277616
[TBL] [Abstract][Full Text] [Related]
23. Regulation of hypoxia-inducible factor-1alpha protein level during hypoxic conditions by the phosphatidylinositol 3-kinase/Akt/glycogen synthase kinase 3beta pathway in HepG2 cells.
Mottet D; Dumont V; Deccache Y; Demazy C; Ninane N; Raes M; Michiels C
J Biol Chem; 2003 Aug; 278(33):31277-85. PubMed ID: 12764143
[TBL] [Abstract][Full Text] [Related]
24. Differential involvement of 5-HT(1A) and 5-HT(1B/1D) receptors in human interferon-alpha-induced immobility in the mouse forced swimming test.
Zhang H; Wang W; Jiang Z; Shang J; Zhang L
Arzneimittelforschung; 2010; 60(3):109-15. PubMed ID: 20422941
[TBL] [Abstract][Full Text] [Related]
25. Chronic treatment with fluoxetine decreases cerebral metabolic responses to the 5-HT1A agonist 8-hydroxy-2(di-N-propylamino)tetralin and increases those to the 5-HT2A/2C agonist 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane and to the dopaminergic agonist apomorphine.
Freo U; Merico A; Ermani M; Ori C
Brain Res; 2010 Jun; 1335():24-34. PubMed ID: 20381465
[TBL] [Abstract][Full Text] [Related]
26. Mechanism of action of the bimodal antidepressant vilazodone: evidence for serotonin1A-receptor-mediated auto-augmentation of extracellular serotonin output.
van Amsterdam C; Seyfried CA
Psychopharmacology (Berl); 2014 Jun; 231(12):2547-58. PubMed ID: 24419272
[TBL] [Abstract][Full Text] [Related]
27. GSK3 activity regulates rhythms in hippocampal clock gene expression and synaptic plasticity.
Besing RC; Rogers CO; Paul JR; Hablitz LM; Johnson RL; McMahon LL; Gamble KL
Hippocampus; 2017 Aug; 27(8):890-898. PubMed ID: 28556462
[TBL] [Abstract][Full Text] [Related]
28. Carbon monoxide protects against hepatic ischemia/reperfusion injury via ROS-dependent Akt signaling and inhibition of glycogen synthase kinase 3β.
Kim HJ; Joe Y; Kong JS; Jeong SO; Cho GJ; Ryter SW; Chung HT
Oxid Med Cell Longev; 2013; 2013():306421. PubMed ID: 24454979
[TBL] [Abstract][Full Text] [Related]
29. Medial prefrontal cortex serotonergic and GABAergic mechanisms modulate the expression of contextual fear: intratelencephalic pathways and differential involvement of cortical subregions.
Almada RC; Coimbra NC; Brandão ML
Neuroscience; 2015 Jan; 284():988-997. PubMed ID: 25451298
[TBL] [Abstract][Full Text] [Related]
30. Selective serotonin reuptake inhibitors potentiate 8-OH-DPAT-induced stimulus control in the pigeon.
Wolff MC; Leander JD
Eur J Pharmacol; 1998 Mar; 345(1):35-9. PubMed ID: 9593591
[TBL] [Abstract][Full Text] [Related]
31. Synergistic neurochemical and behavioral effects of fluoxetine and 5-HT1A receptor antagonists.
Trillat AC; Malagié I; Mathe-Allainmat M; Anmella MC; Jacquot C; Langlois M; Gardier AM
Eur J Pharmacol; 1998 Sep; 357(2-3):179-84. PubMed ID: 9797034
[TBL] [Abstract][Full Text] [Related]
32. Behavioral and neurochemical effects of 5-(4-[4-(5-Cyano-3-indolyl)-butyl)-butyl]-1-piperazinyl)-benzofuran-2-carboxamide (EMD 68843): a combined selective inhibitor of serotonin reuptake and 5-hydroxytryptamine(1A) receptor partial agonist.
Page ME; Cryan JF; Sullivan A; Dalvi A; Saucy B; Manning DR; Lucki I
J Pharmacol Exp Ther; 2002 Sep; 302(3):1220-7. PubMed ID: 12183683
[TBL] [Abstract][Full Text] [Related]
33. Estradiol potentiates 8-OH-DPAT-induced sumoylation of 5-HT₁A receptor: characterization and subcellular distribution of sumoylated 5-HT₁A receptors.
Li Q; Muma NA
Psychoneuroendocrinology; 2013 Nov; 38(11):2542-53. PubMed ID: 23786880
[TBL] [Abstract][Full Text] [Related]
34. 5-HT1A receptors mediate (+)8-OH-DPAT-stimulation of extracellular signal-regulated kinase (MAP kinase) in vivo in rat hypothalamus: time dependence and regional differences.
Crane JW; Shimizu K; Carrasco GA; Garcia F; Jia C; Sullivan NR; D'Souza DN; Zhang Y; Van de Kar LD; Muma NA; Battaglia G
Brain Res; 2007 Dec; 1183():51-9. PubMed ID: 17976547
[TBL] [Abstract][Full Text] [Related]
35. Glycogen synthase kinase-3 levels and phosphorylation undergo large fluctuations in mouse brain during development.
Beurel E; Mines MA; Song L; Jope RS
Bipolar Disord; 2012 Dec; 14(8):822-30. PubMed ID: 23167932
[TBL] [Abstract][Full Text] [Related]
36. Regulation of mouse brain glycogen synthase kinase-3 by atypical antipsychotics.
Li X; Rosborough KM; Friedman AB; Zhu W; Roth KA
Int J Neuropsychopharmacol; 2007 Feb; 10(1):7-19. PubMed ID: 16672106
[TBL] [Abstract][Full Text] [Related]
37. The GSK3 signaling pathway is activated by cocaine and is critical for cocaine conditioned reward in mice.
Miller JS; Barr JL; Harper LJ; Poole RL; Gould TJ; Unterwald EM
PLoS One; 2014; 9(2):e88026. PubMed ID: 24505362
[TBL] [Abstract][Full Text] [Related]
38. Expression of the 5-HT1A serotonin receptor in the hippocampus is required for social stress resilience and the antidepressant-like effects induced by the nicotinic partial agonist cytisine.
Mineur YS; Einstein EB; Bentham MP; Wigestrand MB; Blakeman S; Newbold SA; Picciotto MR
Neuropsychopharmacology; 2015 Mar; 40(4):938-46. PubMed ID: 25288485
[TBL] [Abstract][Full Text] [Related]
39. Oncotoxic Properties of Serotonin Transporter Inhibitors and 5-HT
Walory J; Mielczarek L; Jarończyk M; Koronkiewicz M; Kossakowski J; Bugno R; Bojarski AJ; Chilmonczyk Z
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30347827
[TBL] [Abstract][Full Text] [Related]
40. Fluoxetine-induced changes in body weight and 5-HT1A receptor-mediated hormone secretion in rats on a tryptophan-deficient diet.
D'Souza DN; Zhang Y; Garcia F; Battaglia G; Van de Kar LD
Am J Physiol Regul Integr Comp Physiol; 2004 Feb; 286(2):R390-7. PubMed ID: 14604841
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
